Creo Medical Group PLC (CREO) — Tangible Net Worth Ratio
Creo Medical Group PLC (CREO) has a Tangible Net Worth Ratio of 98.9% as of June 2025. This metric is calculated by deducting intangible assets (GBX700.00K) from net assets (GBX60.90 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CREO current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Creo Medical Group PLC Tangible Net Worth Ratio (2007–2024)
This chart shows how Creo Medical Group PLC's Tangible Net Worth Ratio has changed across 15 annual periods from 2007 to 2024. As of June 2025, the ratio stands at 98.9%, reflecting net assets of GBX60.90 Million with intangible assets of GBX700.00K GBX. See Creo Medical Group PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Creo Medical Group PLC (2007–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Creo Medical Group PLC from 2007 to 2024, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see CREO market cap.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 98.8% | GBX42.40 Million | GBX500.00K | GBX65.00 Million | ▲ +10.7 pp |
| 2023 | 88.1% | GBX59.80 Million | GBX7.10 Million | GBX76.60 Million | ▲ +44.1 pp |
| 2022 | 44.0% | GBX49.40 Million | GBX27.64 Million | GBX75.34 Million | ▼ -18.8 pp |
| 2021 | 62.8% | GBX73.32 Million | GBX27.25 Million | GBX100.61 Million | ▲ +8.3 pp |
| 2020 | 54.6% | GBX62.81 Million | GBX28.53 Million | GBX92.46 Million | ▼ -44.4 pp |
| 2019 | 99.0% | GBX82.66 Million | GBX865.24K | GBX88.26 Million | ▼ -0.4 pp |
| 2018 | 99.4% | GBX47.71 Million | GBX307.81K | GBX49.75 Million | ▼ -0.5 pp |
| 2018 | 99.9% | GBX7.33 Million | GBX7.00K | GBX9.62 Million | ▼ 0.0 pp |
| 2017 | 99.9% | GBX14.65 Million | GBX10.90K | GBX16.12 Million | ▲ +0.7 pp |
| 2016 | 99.2% | GBX1.63 Million | GBX12.88K | GBX2.42 Million | ▼ -0.4 pp |
| 2016 | 99.6% | GBX3.22 Million | GBX12.88K | GBX3.75 Million | ▼ -0.4 pp |
| 2015 | 100.0% | GBX748.41K | GBX0.00 | GBX1.04 Million | ▲ +0.0 pp |
| 2014 | 100.0% | GBX1.37 Million | GBX0.00 | GBX1.62 Million | ▲ +0.0 pp |
| 2008 | 100.0% | GBX113.00K | GBX0.00 | GBX171.00K | ▲ +0.0 pp |
| 2007 | 100.0% | GBX12.00K | GBX0.00 | GBX257.00K | — |